Literature DB >> 17349012

Circulating mononuclear cells from euthyroid patients with thyroid-associated ophthalmopathy exhibit characteristic phenotypes.

R S Douglas1, A G Gianoukakis, R A Goldberg, S Kamat, T J Smith.   

Abstract

Thyroid-associated ophthalmopathy (TAO) is a common yet poorly understood component of Graves' disease involving inflammation, congestion and soft tissue remodelling of the orbit. Unlike most autoimmune disorders, TAO has variable severity but follows a predictable course and is usually self-limited. The objective of this study was to investigate the phenotypic profile of peripheral blood mononuclear cells in euthyroid patients with TAO. The study was a prospective, consecutive analysis of the peripheral blood mononuclear cell phenotype in patients with TAO and normal controls. We demonstrate that the fraction of T cells expressing CD69, CD25 or CXCR4 is significantly greater in patients with TAO compared to control donors. In addition, the fraction of CD19(+) CD25(+) B cells is significantly greater. We did not find differences between the two groups of subjects in monocytes expressing these markers. There is a phenotypic shift in peripheral blood lymphocytes associated with TAO that appears durable and persists beyond the hyperthyroid phase of Graves' disease. These changes may support the immune reaction provoking orbital disease development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17349012      PMCID: PMC1868859          DOI: 10.1111/j.1365-2249.2006.03316.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

Review 1.  Graves' disease.

Authors:  A P Weetman
Journal:  N Engl J Med       Date:  2000-10-26       Impact factor: 91.245

Review 2.  Orbital fibroblasts exhibit a novel pattern of responses to proinflammatory cytokines: potential basis for the pathogenesis of thyroid-associated ophthalmopathy.

Authors:  Terry J Smith
Journal:  Thyroid       Date:  2002-03       Impact factor: 6.568

3.  Reduced expression of stromal-derived factor 1 in autonomous thyroid adenomas and its regulation in thyroid-derived cells.

Authors:  G Aust; M Steinert; S Kiessling; M Kamprad; C Simchen
Journal:  J Clin Endocrinol Metab       Date:  2001-07       Impact factor: 5.958

4.  Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity.

Authors:  S Sebastiani; P Allavena; C Albanesi; F Nasorri; G Bianchi; C Traidl; S Sozzani; G Girolomoni; A Cavani
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

5.  Graves' disease is associated with an altered CXCR3 and CCR5 expression in thyroid-derived compared to peripheral blood lymphocytes.

Authors:  G Aust; D Sittig; M Steinert; P Lamesch; T Lohmann
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

6.  CCR5-binding chemokines modulate CXCL12 (SDF-1)-induced responses of progenitor B cells in human bone marrow through heterologous desensitization of the CXCR4 chemokine receptor.

Authors:  Marek Honczarenko; Yi Le; Aleksandra M Glodek; Marcin Majka; James J Campbell; Mariusz Z Ratajczak; Leslie E Silberstein
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

7.  CD69 downregulates autoimmune reactivity through active transforming growth factor-beta production in collagen-induced arthritis.

Authors:  David Sancho; Manuel Gómez; Fernando Viedma; Enric Esplugues; Mónica Gordón-Alonso; María Angeles García-López; Hortensia de la Fuente; Carlos Martínez-A; Pilar Lauzurica; Francisco Sánchez-Madrid
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

8.  Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis.

Authors:  J J Haringman; T J M Smeets; P Reinders-Blankert; P P Tak
Journal:  Ann Rheum Dis       Date:  2005-08-17       Impact factor: 19.103

9.  Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell-derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue.

Authors:  Paul F Bradfield; Nicole Amft; Elizabeth Vernon-Wilson; Andrew E Exley; Greg Parsonage; G Ed Rainger; Gerard B Nash; Andrew M C Thomas; David L Simmons; Mike Salmon; Christopher D Buckley
Journal:  Arthritis Rheum       Date:  2003-09

10.  Enhanced antitumor immunity in mice deficient in CD69.

Authors:  Enric Esplugues; David Sancho; Javier Vega-Ramos; Carlos Martínez; Uta Syrbe; Alf Hamann; Pablo Engel; Francisco Sánchez-Madrid; Pilar Lauzurica
Journal:  J Exp Med       Date:  2003-05-05       Impact factor: 14.307

View more
  6 in total

Review 1.  Potential role for bone marrow-derived fibrocytes in the orbital fibroblast heterogeneity associated with thyroid-associated ophthalmopathy.

Authors:  T J Smith
Journal:  Clin Exp Immunol       Date:  2010-08-19       Impact factor: 4.330

2.  Cytokines are both villains and potential therapeutic targets in thyroid-associated ophthalmopathy: From bench to bedside.

Authors:  Fatemeh Rajaii; Allison N McCoy; Terry J Smith
Journal:  Expert Rev Ophthalmol       Date:  2014-06

3.  Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy.

Authors:  Dinesh Khanna; Kelvin K L Chong; Nikoo F Afifiyan; Catherine J Hwang; Diana K Lee; Helene Chokron Garneau; Robert A Goldberg; Christine H Darwin; Terry J Smith; Raymond S Douglas
Journal:  Ophthalmology       Date:  2009-10-08       Impact factor: 12.079

4.  Effect of systemic steroid therapy in Graves' orbitopathy on regulatory T cells and Th17/Treg ratio.

Authors:  M Siomkajło; Ł Mizera; D Szymczak; K Kolačkov; J Grzegrzółka; M Bolanowski; J Daroszewski
Journal:  J Endocrinol Invest       Date:  2021-04-17       Impact factor: 4.256

5.  Regulation of Lymphocyte Function by PPARgamma: Relevance to Thyroid Eye Disease-Related Inflammation.

Authors:  G M Lehmann; T M Garcia-Bates; T J Smith; S E Feldon; R P Phipps
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

6.  Increased microRNA-155 and decreased microRNA-146a may promote ocular inflammation and proliferation in Graves' ophthalmopathy.

Authors:  Kaijun Li; Yi Du; Ben-Li Jiang; Jian-Feng He
Journal:  Med Sci Monit       Date:  2014-04-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.